| Mediterranean products as promising source of multi-target agents in the treatment of metabolic syndrome D Bagetta, A Maruca, A Lupia, F Mesiti, R Catalano, I Romeo, F Moraca, ... European journal of medicinal chemistry 186, 111903, 2020 | 78 | 2020 |
| The Mediterranean Diet as source of bioactive compounds with multi-targeting anti-cancer profile A Maruca, R Catalano, D Bagetta, F Mesiti, FA Ambrosio, I Romeo, ... European journal of medicinal chemistry 181, 111579, 2019 | 72 | 2019 |
| Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes E Iaccino, S Mimmi, V Dattilo, F Marino, P Candeloro, A Di Loria, ... Molecular cancer 16, 1-9, 2017 | 62 | 2017 |
| Indole and 2, 4-Thiazolidinedione conjugates as potential anticancer modulators DM Corigliano, R Syed, S Messineo, A Lupia, R Patel, CVR Reddy, ... PeerJ 6, e5386, 2018 | 43 | 2018 |
| Is there a role for dual PI3K/mTOR inhibitors for patients affected with lymphoma? C Tarantelli, A Lupia, A Stathis, F Bertoni International journal of molecular sciences 21 (3), 1060, 2020 | 39 | 2020 |
| Computer-based techniques for lead identification and optimization I: Basics A Maruca, FA Ambrosio, A Lupia, I Romeo, R Rocca, F Moraca, C Talarico, ... Physical Sciences Reviews 4 (6), 20180113, 2019 | 30 | 2019 |
| A computer-assisted discovery of novel potential anti-obesity compounds as selective carbonic anhydrase VA inhibitors G Costa, F Carta, FA Ambrosio, A Artese, F Ortuso, F Moraca, R Rocca, ... European Journal of Medicinal Chemistry 181, 111565, 2019 | 28 | 2019 |
| Current updates on naturally occurring compounds recognizing SARS-CoV-2 druggable targets I Romeo, F Mesiti, A Lupia, S Alcaro Molecules 26 (3), 632, 2021 | 26 | 2021 |
| Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients S Mimmi, E Vecchio, E Iaccino, M Rossi, A Lupia, F Albano, F Chiurazzi, ... Leukemia 30 (12), 2419-2422, 2016 | 24 | 2016 |
| Inside perspective of the synthetic and computational toolbox of JAK inhibitors: Recent updates A Coricello, F Mesiti, A Lupia, A Maruca, S Alcaro Molecules 25 (15), 3321, 2020 | 23 | 2020 |
| Review about the multi-target profile of resveratrol and its implication in the SGK1 inhibition G Catalogna, F Moraca, L D'Antona, V Dattilo, G Perrotti, A Lupia, G Costa, ... European Journal of Medicinal Chemistry 183, 111675, 2019 | 23 | 2019 |
| Molecular modelling of epitopes recognized by neoplastic B lymphocytes in Chronic Lymphocytic Leukemia A Lupia, S Mimmi, E Iaccino, D Maisano, F Moraca, C Talarico, E Vecchio, ... European Journal of Medicinal Chemistry 185, 111838, 2020 | 18 | 2020 |
| Targeting multiple G-quadruplex–forming DNA sequences: Design, biophysical and biological evaluations of indolo-naphthyridine scaffold derivatives R Catalano, F Moraca, J Amato, C Cristofari, R Rigo, L Dalla Via, R Rocca, ... European Journal of Medicinal Chemistry 182, 111627, 2019 | 17 | 2019 |
| Computer-based techniques for lead identification and optimization II: Advanced search methods A Lupia, F Moraca, D Bagetta, A Maruca, FA Ambrosio, R Rocca, ... Physical Sciences Reviews 5 (5), 20180114, 2020 | 16 | 2020 |
| Peptide Platform as a Powerful Tool in the Fight against COVID-19 M Murdocca, G Citro, I Romeo, A Lupia, S Miersch, B Amadio, A Bonomo, ... Viruses 13 (8), 1667, 2021 | 10 | 2021 |
| Multi-targeting bioactive compounds extracted from essential oils as kinase inhibitors A Maruca, D Lanzillotta, R Rocca, A Lupia, G Costa, R Catalano, ... Molecules 25 (9), 2174, 2020 | 10 | 2020 |
| Ligand-based drug repurposing strategy identified SARS-CoV-2 RNA G-quadruplex binders F Moraca, S Marzano, F D'Amico, A Lupia, S Di Fonzo, E Vertecchi, ... Chemical Communications 58 (85), 11913-11916, 2022 | 8 | 2022 |
| Identification of compounds targeting HuD. Another brick in the wall of neurodegenerative disease treatment FA Ambrosio, A Coricello, G Costa, A Lupia, M Micaelli, N Marchesi, ... Journal of Medicinal Chemistry 64 (14), 9989-10000, 2021 | 8 | 2021 |
| Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma C Di Giorgio, R Bellini, A Lupia, C Massa, M Bordoni, S Marchianò, ... Frontiers in Oncology 13, 1140730, 2023 | 5 | 2023 |
| Repositioning mifepristone as a leukaemia inhibitory factor receptor antagonist for the treatment of pancreatic adenocarcinoma C Di Giorgio, A Lupia, S Marchianò, M Bordoni, R Bellini, C Massa, ... Cells 11 (21), 3482, 2022 | 4 | 2022 |
